[February 13, 2012]

Heartbeat Experts Announces 20 New Asia-Pacific KOL Management Projects Sold in Fourth Quarter

Heartbeat Experts reported today selling 20 KOL identification and KOL management software projects in the Asia-Pacific region in the fourth quarter of 2011. These projects include implementations in China, Japan, Korea, India, Indonesia and Australia. The company reported that its clients span pharmaceutical, medical device and diagnostics manufacturers.

Implementation of these projects, led by Heartbeat Experts' local delivery team in each country, involves the company's KOL management software platform populated with profiles of identified KOLs. The KOL profiles are built from public sources in the KOL's local language in accordance with each country's data privacy laws.

Larry Cohen (News - Alert), President of Heartbeat Experts, said, "This announcement affirms our position as the leader in Asia-Pacific for KOL management solutions. As emerging markets become critical to the growth of life science companies, they are looking to our global expertise in KOL mapping combined with local presence. Our local teams deliver projects tailored to each country's language and regulations."

Keren Priyadarshini, Head of Asia for Heartbeat Experts, added, "These 20 new clients reflect the continuing importance of structured KOL management for APAC clients. They are recognizing the impact KOLs have on the success of their products. In effectively selecting the right KOLs for each business need, Heartbeat Experts' methodology explores beyond more limited traditional KOL identification techniques. Implementing structured KOL management software leads to a higher return on investment from KOL engagements."

About Heartbeat Experts:

Heartbeat Experts works with over 150 clients on KOL management and market access projects. Working from offices in Europe, Asia-Pacific, Latin America and North America, Heartbeat Experts' software and data analytics solutions have been implemented for pharmaceutical, medical device, biotechnology, diagnostics and vaccine firms.

[ Back To TMCnet.com's Homepage ]